“…As discussed above, brain CB1R distribution, synthesis of endogenous cannabinoids and activity of enzymes involved in cannabinoid metabolism (turnover) are significantly affected by sex hormones. At systems level, hormone-dependent differences and fluctuations in cannabinoid function may directly affect the activity of brain neurotransmitters and structures involved in cognitive and emotional aspects of motivated behaviors ( Schultz, 1997 ; Berridge and Robinson, 1998 ; Ikemoto and Panksepp, 1999 ; Salamone and Correa, 2002 ; Goto and Grace, 2005 ; Cheng and Feenstra, 2006 ; Di Chiara and Bassareo, 2007 ; Berridge et al, 2009 ), like feeding ( Melis et al, 2007 ; Bassareo et al, 2015 ; Fois et al, 2016 ; Coccurello and Maccarrone, 2018 ; Contini et al, 2018 ) and sexual behavior ( Pfaus et al, 1990 ; Pfaus and Everitt, 1995 ; Sanna et al, 2015 , 2017 ) as well as psychopathological states ( Dunlop and Nemeroff, 2007 ; Maia and Frank, 2017 ) and addiction-like behaviors ( Everitt and Robbins, 2005 , 2016 ). Such a modulation can happen (i) by a direct interaction of the cannabinoid system with the mesolimbic dopaminergic system, the core component of the neurobiological substrates at the basis of motivated behavior ( Gardner, 2005 ; Fadda et al, 2006 ; Lecca et al, 2006 ; Zangen et al, 2006 ; Melis and Pistis, 2007 ; Panagis et al, 2014 ; Bloomfield et al, 2016 ; Maldonado et al, 2006 ), or (ii) by indirect actions in limbic areas (e.g., hippocampus, amygdala, PFC) strictly interconnected with mesolimbic dopaminergic neurons through (mainly) glutamatergic projections to the ventral tegmental area and nucleus accumbens ( Laviolette and Grace, 2006 ; Laviolette, 2017 ).…”